Insider Buying: Accelerate Diagnostics Director Purchases 2,900 Shares of Stock (AXDX)
Accelerate Diagnostics (NASDAQ:AXDX) Director Jack W. Schuler purchased 2,900 shares of Accelerate Diagnostics stock in a transaction dated Thursday, August 21st. The shares were purchased at an average cost of $16.79 per share, with a total value of $48,691.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Accelerate Diagnostics (NASDAQ:AXDX) traded up 12.49% on Monday, hitting $20.72. The stock had a trading volume of 588,635 shares. Accelerate Diagnostics has a 1-year low of $8.89 and a 1-year high of $31.86. The stock’s 50-day moving average is $19.44 and its 200-day moving average is $19.63. The company’s market cap is $923.8 million.
Accelerate Diagnostics, Inc, formerly Accelr8 Technology Corporation, is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens.
Receive News & Ratings for Accelerate Diagnostics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accelerate Diagnostics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.